{"nct_id":"NCT00742560","title":"A Phase 1b/2, Dose-Escalation Study of Elotuzumab (Humanized Anti-CS1 Monoclonal IgG1 Antibody) in Relapsed Multiple Myeloma","status":"COMPLETED","status_verified_date":"2018-01","start_date":"2008-08","start_date_type":null,"primary_completion_date":"2016-10","primary_completion_date_type":"ACTUAL","completion_date":"2016-10","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["ABBV"]}